Trial reportNutrients2026
Effects of Short-Term Low- and High-Dose New Zealand Blackcurrant Supplementation on Exercise and Cognitive Performance in Resistance-Trained Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
Trial report in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNew Zealand blackcurrant (NZBC) is an anthocyanin-rich supplement with reported ergogenic effects in endurance exercise; however, its effects in resistance-trained adults remain largely unexplored.
objectiveThis study aimed to examine whether seven days of low- or high-dose NZBC supplementation improves resistance exercise performance, anaerobic capacity, and cognitive function in resistance-trained adults.
methodsTwenty resistance-trained adults completed a randomized, double-blind, placebo-controlled crossover trial with four conditions: no-capsule control (CON), placebo (PL), low-dose blackcurrant (LDBC; 250 mg·day
resultsLDBC and HDBC increased bench press 1RM versus CON and PL, with increases versus CON of +3.33 kg (ES = 0.72;
conclusionsShort-term NZBC supplementation improved selected resistance-exercise and cognitive outcomes, with the strongest evidence observed for outcomes that exceeded both CON and PL. The PL response relative to CON suggests that non-specific capsule, expectancy, repeated testing, or period effects may have contributed to some of the lower-body improvements; therefore, placebo-controlled contrasts should be emphasized when interpreting NZBC-specific efficacy. Wingate performance was unaffected, and both doses were well tolerated over the short-term supplementation period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.